Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy Academic Article uri icon

Overview

MeSH Major

  • Breast Neoplasms
  • Combined Modality Therapy

abstract

  • Excellent 5-year locoregional and distant control rates were achievable in patients with TNBC who had tumors ≤1.0 cm, 58% of whom received chemotherapy. These results identified a group of patients with TNBC who had favorable outcomes after early detection and multimodality treatment.

publication date

  • October 15, 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.27480

PubMed ID

  • 22392492

Additional Document Info

start page

  • 4944

end page

  • 52

volume

  • 118

number

  • 20